Antiviral therapy in hepatitis B virus-infected immunotolerant children, exploring a new land
Author(s):
Mohamed Aly Mokhles
Mohamed Aly Mokhles
Affiliations:
Corresponding author. Address: 45 Zahraa El Helmia Towers, Gesr El Suez, Cairo, Egypt. Tel.: +201223407520; fax:+20233370931.
EASL LiverTree™. Mokhles M.
Nov 1, 2018; 256722
Prof. Dr. Mohamed Aly Mokhles
Prof. Dr. Mohamed Aly Mokhles

Access to this content is an EASL members and LiverTree™ Privileged Users benefit.

Journal Abstract
References
Discussion Forum (0)
Rate & Comment (0)
This article does not have an abstract to display.
[1]. Shishu Zhu - Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: a pilot open-label randomized study
[2]. N.A. Terrault - AASLD guidelines for treatment of chronic hepatitis B
[4]. U. Poddar - Cure for immune-tolerant hepatitis B in children: is it an achievable target with sequential combo therapy with lamivudine and interferon?
[5]. L. D'Antiga - Combined lamivudine/interferon-alpha treatment in “immunotolerant” children perinatally Infected with hepatitis B: a pilot study
[6]. W.P. Brouwer - Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: a multicenter randomized trial (ARES study)
[7]. G.-J. Li - Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment
[8]. H. Chi - Addition of peginterferon alfa-2B during long-term nucleos(T)ide analogue therapy increases hbeag seroconversion and hbsag decline-week 48 results from a multicenter randomized controlled trial (pegon study)
[9]. P. Lampertico - LP25: Add-on peginterferon ALFA-2A significantly reduces hbsag levels in hbeag-negative, genotype d chronic hepatitis b patients fully suppressed on nucleot(s)ide analogue treatment: The HERMES study
[10]. M. Bourlière - Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial
[11]. Dark side of the moon. Pink Floyd album 1973.
[12]. High hopes. From Pink Floyd album the division bell.1994.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings